Vanguard National Trust Co
BankPosition in NTLA — Intellia Therapeutics, Inc.
CIK 1984256
MALVERN, PA
Position in NTLA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,101
+$2,448 QoQ
Shares Held
597
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#270
of 327 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vanguard National Trust Co holds $396,472 across 10 Biotechnology names. NTLA ranks #4 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256 | $159,626 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
294 | $146,038 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
1,000 | $57,220 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
This page
|
597 | $10,101 | |
| 5 | MRNA |
Moderna, Inc.
|
98 | $6,862 | |
| 6 | BNTX |
BioNTech SE
|
61 | $5,676 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
302 | $5,254 | |
| 8 | INSM |
INSMED Inc
|
29 | $3,091 |
All Filings in NTLA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,101 | 597 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,653 | 597 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||